TABLE 12: Treatment - radiotherapy

% of Cases treated with Radiotherapy
UKIACR average (population) UKIACR average (country) England Scotland Northern Ireland Wales
All invasive xnmsc 20.7% 20.2% 20.8% 18.7% - 21.2%
All xnmsc 0-24 15.0% 14.3% 15.1% 14.3% - 13.4%
All xnmsc 25-59 23.8% 25.2% 23.5% 25.2% - 26.9%
All xnmsc 60-79 22.8% 21.8% 23.2% 19.3% - 22.9%
All xnmsc 80+ 12.1% 11.3% 12.3% 9.8% - 12.0%
Haematology 9.3% 8.7% 9.5% 7.6% - 9.0%
Head and Neck 58.3% 56.7% 59.4% 46.2% - 64.4%
Lower GI 13.0% 12.9% 13.0% 13.0% - 12.6%
Upper GI 19.4% 19.0% 19.6% 15.2% - 22.1%
HPB 2.5% 2.2% 2.7% 1.3% - 2.8%
Trachea, Bronchus & Lung 26.1% 26.0% 26.1% 26.8% - 25.2%
Melanoma of skin 0.8% 0.6% 0.8% 0.1% - 0.8%
Breast 37.8% 39.4% 37.4% 40.1% - 40.8%
Cervix 41.4% 45.8% 40.2% 46.1% - 51.2%
Other Female Genitals 16.5% 18.3% 16.2% 14.3% - 24.5%
Prostate 19.5% 13.8% 20.9% 5.9% - 14.5%
Kidney 5.0% 5.0% 5.1% 4.4% - 5.5%
Bladder 17.3% 18.9% 16.9% 17.5% - 22.4%
Brain and CNS 46.8% 45.9% 47.2% 42.7% - 47.8%
Thyroid & other endocrine glands 28.7% 25.5% 30.0% 14.3% - 32.3%
CUP 11.8% 12.0% 11.8% 10.3% - 13.9%
Other invasive cancer 14.6% 13.5% 15.1% 10.2% - 15.3%
Breast in situ 32.5% 34.0% 32.2% 38.6% - 31.3%
Cervix in situ 0.0% 0.0% 0.0% 0.0% - 0.0%
Other tumours 1.2% 0.8% 1.3% 0.2% - 0.9%
Non-Melanoma Skin Cancer 1.8% 1.2% 1.9% 0.6% - 1.1%